Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (791-800 of 992) with videos related to

Pageof 100
Sort By:
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|October 9, 2019
The Role of <i>Staphylococcus aureus</i> in Mastitis : A Multidisciplinary Working Group ExperienceSara Giordana Rimoldi, Paola Pileri, Martina Ilaria Mazzocco, et al.
Plos One|September 7, 2012
The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilinMaria R Ambrosio, Pier P Piccaluga, Maurilio Ponzoni, et al.
Leukemia & Lymphoma|June 30, 2004
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphomaPier Luigi Zinzani, Alessandro Pulsoni, Patrizia Gentilini, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
Haematologica|May 9, 2000
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patientsA Palumbo, S Triolo, L Baldini, et al.
Haematologica|September 1, 1996
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patientsA Levis, L Depaoli, M Bertini, et al.
Oncotarget|August 28, 2016
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancerAlberto Grandi, Alice Santi, Susanna Campagnoli, et al.
Leukemia & Lymphoma|October 10, 2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphomaEnrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Pageof 100

Showing results (791-800 of 992) with videos related to

Sort By:
Pageof 100
Journal of Human Lactation : Official Journal of International Lactation Consultant Association|October 9, 2019
The Role of <i>Staphylococcus aureus</i> in Mastitis : A Multidisciplinary Working Group ExperienceSara Giordana Rimoldi, Paola Pileri, Martina Ilaria Mazzocco, et al.
Plos One|September 7, 2012
The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilinMaria R Ambrosio, Pier P Piccaluga, Maurilio Ponzoni, et al.
Leukemia & Lymphoma|June 30, 2004
Effectiveness of fludarabine, idarubicin and cyclophosphamide (FLUIC) combination regimen for young patients with untreated non-follicular low-grade non-Hodgkin's lymphomaPier Luigi Zinzani, Alessandro Pulsoni, Patrizia Gentilini, et al.
Blood|June 29, 2012
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaLuca Agnelli, Elisabetta Mereu, Elisa Pellegrino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth controlL Leoncini, C Bellan, A Cossu, et al.
Haematologica|May 9, 2000
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patientsA Palumbo, S Triolo, L Baldini, et al.
Haematologica|September 1, 1996
Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patientsA Levis, L Depaoli, M Bertini, et al.
Oncotarget|August 28, 2016
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancerAlberto Grandi, Alice Santi, Susanna Campagnoli, et al.
Leukemia & Lymphoma|October 10, 2009
Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphomaEnrico Derenzini, Vittorio Stefoni, Cinzia Pellegrini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2013
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaM Dreyling, C Thieblemont, A Gallamini, et al.
Pageof 100